The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Is The Expected Market Value Outlook For The Angioplasty Balloons Market Through 2030?
The angioplasty balloons market has experienced consistent growth in its size over recent years. It is projected to expand from $2.85 billion in 2025 to reach $2.98 billion by 2026, driven by a compound annual growth rate (CAGR) of 4.6%. In the past, this growth was primarily influenced by an escalating prevalence of coronary artery disease, the increased clinical adoption of percutaneous transluminal angioplasty, an augmentation in hospital catheterization laboratory capacity, the timely introduction of standard and compliant balloon catheters, and a widening impact of peripheral artery disease.
The angioplasty balloons market size is projected to experience consistent expansion in the upcoming years. This market is anticipated to reach $3.47 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 3.9%. Key factors driving this growth over the forecast period include the escalating demand for drug-eluting and specialized balloons, a surge in procedural volumes for peripheral angioplasty, the expansion of treatments for complex lesions needing scoring and cutting balloons, the broadening uptake of minimally invasive cardiovascular interventions, and increased capital allocation in interventional cardiology infrastructure. Significant trends identified for this period encompass the wider acceptance of drug-eluting balloons for intricate coronary and peripheral lesions, a greater deployment of non-compliant and semi-compliant balloons to refine procedural accuracy, an increasing inclination towards scoring and cutting balloons for resistant and calcified narrowings, the widening scope of minimally invasive angioplasty procedures across both cardiology and vascular care, and a developing clinical inclination towards balloon-based revascularization for individuals where stenting is not appropriate.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15509&type=smp
What Primary Factors Are Fueling The Expansion Of The Angioplasty Balloons Market?
The angioplasty balloons market is anticipated to expand moving forward, driven by the increasing occurrence of cardiovascular diseases. These diseases represent a collection of ailments affecting the heart and blood vessels, frequently resulting in complications such as heart attacks or strokes. The rise in cardiovascular disease cases is attributed to inactive lifestyles, unhealthy eating habits, increasing obesity rates, and an aging population. Angioplasty balloons are employed in the treatment of cardiovascular disease to widen constricted or blocked blood vessels, thereby re-establishing proper blood flow and diminishing the risk of complications like heart attacks or strokes. For instance, in September 2024, data published by the Minnesota Department of Health, a US-based state health agency, revealed that approximately 30% of adults in Minnesota reported experiencing high blood pressure in 2023, totaling nearly 1.4 million people. Moreover, in 2022, hypertensive diseases were identified as the underlying or contributing cause of death for 14,225 residents, accounting for almost 28% of all deaths in the state. Consequently, the growing prevalence of cardiovascular diseases is a key factor propelling the growth of the angioplasty balloons market.
Which Segment-Based Categories Are Covered In The Angioplasty Balloons Market?
The angioplasty balloons market covered in this report is segmented –
1) By Product Type: Normal Balloons, Scoring Balloons, Drug-Eluting Balloons, Cutting Balloons
2) By Material: Non-Compliant, Semi-Compliant
3) By Application: Coronary Angioplasty, Peripheral Angioplasty
4) By End User: Hospitals, Specialty Clinics, Catheterization Laboratories, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Normal Balloons: Non-Compliant Balloons, Compliant Balloons
2) By Scoring Balloons: Semi-Compliant Scoring Balloons, Non-Compliant Scoring Balloons
3) By Drug-Eluting Balloons: Paclitaxel-Eluting Balloons, Sirolimus-Eluting Balloons, Everolimus-Eluting Balloons
4) By Cutting Balloons: Balloon Catheters With Cutting Blades, Balloon Catheters With Radial Scoring Elements
Which Trends Are Supporting The Evolution Of The Angioplasty Balloons Market?
Major companies in the angioplasty balloons market are concentrating on developing groundbreaking products, such as sophisticated medical balloon forming systems, to enhance precision in manufacturing high-pressure balloons for crucial cardiac procedures. The Advanced Medical Balloon Forming System represents a technology designed for the exact production of compliant medical balloons used in catheter systems. For example, in June 2024, Interface Catheter Solutions, an innovative catheter technology company from the US, introduced the BFM-5510 High Force Balloon Forming Machine. This advanced benchtop system is specifically engineered for producing low- and non-compliant polymer balloons utilized in angioplasty, stent placement, and other vital cardiac interventions. Building on the BFM-3310 platform, the BFM-5510 HF employs beryllium copper molds to accurately shape extruded balloon tubing, ensuring stringent quality and tight tolerances across a wide array of sizes and shapes. This machine provides enhanced production capabilities to accommodate the requirements for manufacturing larger, thicker, and more complex medical balloons.
Who Are The Leading Firms Participating In The Angioplasty Balloons Market?
Major companies operating in the angioplasty balloons market are Johnson & Johnson, Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, B. Braun SE, Terumo Corporation, Cook Medical, Biotronik SE, Merit Medical Systems Inc, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, AngioDynamics, Cordis, iVascular, Hexacath, Balton Sp, Cardionovum, QualiMed Innovative Medizinprodukte GmbH, Translumina GmbH, Concept Medical Inc
Access The Complete Angioplasty Balloons Market Report:
https://www.thebusinessresearchcompany.com/report/angioplasty-balloons-global-market-report
Which Regional Market Leads The Angioplasty Balloons Market?
North America was the largest region in the angioplasty balloons market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angioplasty balloons market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Customized Angioplasty Balloons Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=15509&type=smp
Browse Through More Reports Similar to the Global Angioplasty Balloons Market 2026, By The Business Research Company
Biopsy Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report
Balloon Valvuloplasty Device Market Report 2026
https://www.thebusinessresearchcompany.com/report/balloon-valvuloplasty-device-global-market-report
Angio Suites Market Report 2026
https://www.thebusinessresearchcompany.com/report/angio-suites-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model